Knockdown of EBV-encoded circRNA circRPMS1 suppresses nasopharyngeal carcinoma cell proliferation and metastasis through sponging multiple miRNAs

References

• Chua M, Wee J, Hui EP, Chan A. Nasopharyngeal carcinoma. Lancet. 2016;387(10022):1012–1024. doi:10.1016/S0140-6736(15)00055-026321262
   PubMed Web of Science ®Google Scholar
• Zhao CX, Zhu W, Ba ZQ, et al. The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. Am J Cancer Res. 2018;8(11):2185–2209.30555738
   PubMed Web of Science ®Google Scholar
• Li H, Liu S, Hu J, et al. Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis. Int J Biol Sci. 2016;12(11):1309–1318. doi:10.7150/ijbs.1656427877083
   PubMed Web of Science ®Google Scholar
• Wang M, Yu F, Wu W, et al. Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. Int J Biol Sci. 2018;14(5):565–576. doi:10.7150/ijbs.2456229805308
   PubMed Web of Science ®Google Scholar
• Cheng S, Li Z, He J, et al. Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3/RIG-I-mediated VCAM-1 expression. Biochim Biophys Acta Mol Basis Dis. 2019;1865(6):1201–1213. doi:10.1016/j.bbadis.2019.01.01530659926
   PubMed Web of Science ®Google Scholar
• Fan C, Tang Y, Wang J, et al. The emerging role of Epstein-Barr virus encoded microRNAs in nasopharyngeal carcinoma. J Cancer. 2018;9(16):2852–2864. doi:10.7150/jca.2546030123354
   PubMed Web of Science ®Google Scholar
• Zuo L, Yue W, Du S, et al. An update: Epstein-Barr virus and immune evasion via microRNA regulation. Virol Sin. 2017;32(3):175–187. doi:10.1007/s12250-017-3996-528669004
   PubMed Web of Science ®Google Scholar
• Li H, Hu J, Luo X, et al. Therapies based on targeting Epstein-Barr virus lytic replication for EBV-associated malignancies. Cancer Sci. 2018;109(7):2101–2108. doi:10.1111/cas.1363429751367
   PubMed Web of Science ®Google Scholar
• He B, Li W, Wu Y, et al. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103. Cell Death Dis. 2016;7(9):e2353. doi:10.1038/cddis.2016.25327584792
   PubMedGoogle Scholar
• Chen L, Zhou H, Guan Z. CircRNA_000543 knockdown sensitizes nasopharyngeal carcinoma to irradiation by targeting miR-9/platelet-derived growth factor receptor B axis. Biochem Biophys Res Commun. 2019;512(4):786–792. doi:10.1016/j.bbrc.2019.03.12630928094
   PubMed Web of Science ®Google Scholar
• Toptan T, Abere B, Nalesnik MA, et al. Circular DNA tumor viruses make circular RNAs. Proc Natl Acad Sci U S A. 2018;115(37):E8737–E8745. doi:10.1073/pnas.181172811530150410
   PubMed Web of Science ®Google Scholar
• Huang JT, Chen JN, Gong LP, et al. Identification of virus-encoded circular RNA. Virology. 2019;529:144–151. doi:10.1016/j.virol.2019.01.01430710798
   PubMed Web of Science ®Google Scholar
• Imai S, Nishikawa J, Takada K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol. 1998;72(5):4371–4378.9557727
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25(4):402–408. doi:10.1006/meth.2001.126211846609
   PubMed Web of Science ®Google Scholar
• Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A. 2009;106(28):11667–11672. doi:10.1073/pnas.090471510619571010
   PubMed Web of Science ®Google Scholar
• Kamran SC, Riaz N, Lee N. Nasopharyngeal carcinoma. Surg Oncol Clin N Am. 2015;24(3):547–561. doi:10.1016/j.soc.2015.03.00825979399
   PubMed Web of Science ®Google Scholar
• Hui KF, Yiu S, Tam KP, Chiang A. Viral-targeted strategies against EBV-associated lymphoproliferative diseases. Front Oncol. 2019;9:81. doi:10.3389/fonc.2019.0008130873380
   PubMed Web of Science ®Google Scholar
• Lin C, Zong J, Lin W, et al. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-kappaB and Erk1/2 pathways. J Exp Clin Cancer Res. 2018;37(1):283. doi:10.1186/s13046-018-0953-630477559
   PubMedGoogle Scholar
• Lyu X, Wang J, Guo X, et al. EBV-miR-BART1-5P activates AMPK/mTOR/HIF1 pathway via a PTEN independent manner to promote glycolysis and angiogenesis in nasopharyngeal carcinoma. PLoS Pathog. 2018;14(12):e1007484. doi:10.1371/journal.ppat.100748430557400
   PubMed Web of Science ®Google Scholar
• Gao W, Wong TS, Lv KX, et al. Detection of Epstein-Barr virus (EBV)-encoded microRNAs in plasma of patients with nasopharyngeal carcinoma. Head Neck. 2019;41(3):780–792. doi:10.1002/hed.2554430548946
   PubMed Web of Science ®Google Scholar
• Jiang C, Chen J, Xie S, et al. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma. Int J Cancer. 2018;143(12):3209–3217. doi:10.1002/ijc.3164229971780
   PubMed Web of Science ®Google Scholar
• Zheng X, Wang J, Wei L, et al. Epstein-Barr virus MicroRNA miR-BART5-3p inhibits p53 expression. J Virol. 2018;92(23). doi:10.1128/JVI.02230-17
   Web of Science ®Google Scholar
• Wang Y, Guo Z, Shu Y, et al. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma. Eur J Cancer Prev. 2017;26(2):144–150. doi:10.1097/CEJ.000000000000022126909566
   PubMed Web of Science ®Google Scholar
• Qu JQ, Yi HM, Ye X, et al. MiRNA-203 reduces nasopharyngeal carcinoma radioresistance by targeting IL8/AKT signaling. Mol Cancer Ther. 2015;14(11):2653–2664. doi:10.1158/1535-7163.MCT-15-046126304234
   PubMed Web of Science ®Google Scholar
• Cheung CC, Chung GT, Lun SW, et al. miR-31 is consistently inactivated in EBV-associated nasopharyngeal carcinoma and contributes to its tumorigenesis. Mol Cancer. 2014;13:184. doi:10.1186/1476-4598-13-18425098679
   PubMed Web of Science ®Google Scholar
• Liu N, Jiang N, Guo R, et al. MiR-451 inhibits cell growth and invasion by targeting MIF and is associated with survival in nasopharyngeal carcinoma. Mol Cancer. 2013;12(1):123. doi:10.1186/1476-4598-12-12324138931
   PubMedGoogle Scholar
• Hu H, Xu Z, Li C, et al. MiR-145 and miR-203 represses TGF-beta-induced epithelial-mesenchymal transition and invasion by inhibiting SMAD3 in non-small cell lung cancer cells. Lung Cancer. 2016;97:87–94. doi:10.1016/j.lungcan.2016.04.01727237033
   PubMed Web of Science ®Google Scholar
• You W, Xu L, Zhang X, et al. High-throughput screening identifies miR-451 as a pleiotropic modulator that suppresses gastric cancer metastasis. SLAS Technol. 2017;22(2):136–143. doi:10.1177/221106821667585827780852
   PubMed Web of Science ®Google Scholar
• Gao Y, Yi J, Zhang K, et al. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36(1):161. doi:10.1186/s13046-017-0622-129145896
   PubMedGoogle Scholar